Diversity in the Clinical Trial Workforce

KEY DETAILS

Join CenExel Chief Commercial Officer, Casey Orvin, as he talks with leaders in the clinical research industry to discuss diversity in the workforce. Part one of our free two-part series, Diversity in the Clinical Trial Workforce will explore this sensitive and exciting topic facing our industry today.

Read more

Today, more than ever, diversity and inclusion within the clinical trial workforce is a responsibility to stakeholders such as sponsors, investors, and vendors in clinical trial research, who are seeking companies that align with their core values. A diverse workforce drives innovation, creativity, and productivity, and creates a thriving culture of belonging that is fundamental for success in advancing the capabilities and effectiveness of clinical research. But workforce culture transformation requires sustainable initiatives that begin with site leadership.

Date: On-Demand
Length: 30 minutes
Topic: Diversity
Price: $0

Presented by CenExel

REGISTER NOW

Name(Required)
Consent(Required)

PRESENTERS

Amanda Rangel, MS, CCRC
Senior Vice President, Business Development
Total Diversity

Amanda is an experienced entrepreneur, business development and operations executive with a 20-year history of success in the clinical research industry. Knowledgeable in selling virtual technology products for decentralized clinical trials, individual site, and site network services, as well as co-selling within a CRO and patient recruitment services environment. Proficient in clinical site operations having managed a US based site network and founding and operating an independent site network business.

Casey Orvin
Chief Commercial Officer
CenExel

Casey has a long and exemplary career history in pharmaceutical research services. Most recently, he was serving as the Senior VP of Pharmaceutical Relationships at StudyKik, a full-service patient recruitment and retention technology company. Casey was also recently serving as the Honorary President of the Society for Clinical Research Sites (SCRS), a global organization representing nearly 10,000 clinical research sites in 47 countries within the pharmaceutical industry.

Read more

Casey began his career leading a large pharmaceutical research site network, Research Solutions. In 2007, he was recruited to join Clinical Research Advantage/Radiant as Executive Vice President of Business Development and successfully led a network of over 75 research sites conducting clinical trials for pharmaceuticals, vaccines, and medical devices. Under Casey’s leadership, several crucial partnerships were formed with major pharmaceutical companies which fueled the company’s rapid growth both geographically and within the medical community. Casey facilitated the acquisition of two competitors securing the company’s spot as what was at the time the largest clinical research site network in the US. In 2015, Casey and the executive team at Radiant merged with Synexus, a division of PPD. With Casey’s guidance, Synexus continued to expand to 215 global clinical sites in 4 continents and over 15 countries.

Casey is passionate about representing the site voice within the industry while ensuring every research patient’s journey is a positive one. As a thought leader in the industry, Casey is regularly invited to be a keynote speaker and panelist and is often quoted by the leading publications covering the clinical research landscape. In 2020, he was recognized in PharmaVoice as one of the 100 Most Inspiring People in the industry.

Casey leads the business development efforts for CenExel, now the U.S. leader of independent clinical research sites.

Elia Acevedo-Diaz, MD
Principal Investigator
CenExel CBH

Elia developed her interest in the research and development of new therapeutics for psychiatric disorders at the National Institutes of Health, Intramural Program. She joined the Experimental Therapeutics and Pathophysiology Branch of the National Institute of Mental Health (NIMH) as a clinical fellow after completing 3 years of psychiatry residency at Boston University. During her time at the NIMH, she participated in important advances in pharmacotherapy of treatment resistant depression. She has an extensive background in psychopharmacology and the evaluation and treatment of mood disorders, anxiety, and schizophrenia. She has several academic publications and is a Diplomate of the American Board of Psychiatry and Neurology.

Sarah Kazmi, MD
VP and General Manager
CenExel ACMR

Dr. Kazmi has over 15 years of extensive experience in Phase I-IV clinical trials spanning many therapeutic areas. She has a strong leadership background and a proven track record of managing large clinical research sites.

Sergio Armani
VP, Head of Large Pharma & CRO Partnerships
Advarra

Sergio has been working on the clinical trials industry for twelve years and is currently the VP of Large Pharma and CRO Partnerships at Advarra. In addition to his role at Advarra, Sergio is a member of the ACRP Board of Trustees as Treasurer and is also president of the Greater Philadelphia Chapter of ACRP where he is involved with introducing minorities to careers in clinical research though talks at local high schools and colleges.

© 2022 CenExel Clinical Research - CAREERS | PRIVACY POLICY | XML SITEMAP | HTML SITEMAP